BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22184289)

  • 1. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1.
    Velpula KK; Dasari VR; Tsung AJ; Dinh DH; Rao JS
    Oncotarget; 2011 Dec; 2(12):1028-42. PubMed ID: 22184289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.
    Chang YW; Su YJ; Hsiao M; Wei KC; Lin WH; Liang CL; Chen SC; Lee JL
    Cancer Res; 2015 Aug; 75(16):3398-410. PubMed ID: 26122848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
    Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
    J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.
    Mitra A; Satelli A; Xia X; Cutrera J; Mishra L; Li S
    Int J Cancer; 2015 Jul; 137(2):491-6. PubMed ID: 25487874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.
    Pirozzi G; Tirino V; Camerlingo R; Franco R; La Rocca A; Liguori E; Martucci N; Paino F; Normanno N; Rocco G
    PLoS One; 2011; 6(6):e21548. PubMed ID: 21738704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
    Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
    Yeeravalli R; Kaushik K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Kang S; Oh SC; Min BW; Lee DH
    Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
    Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
    Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
    Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
    Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.